A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of AMG 510 in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreak 100)
a study on Solid Tumor
KRAS p.G12C Mutant Advanced Solid Tumors Neoplasms AMG 510
Lead Scientist at UCSF
- Pamela Munster
Professor, Medicine. Authored (or co-authored) 124 research publications.